Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 10
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (3975)
- Volume 19, 2023 (118)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 10, 2014
Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo
Yanik ME, Erfan G, Albayrak Y, Aydin M, Kulac M, Kuloglu M
Neuropsychiatric Disease and Treatment 2014, 10:2361-2367
Published Date: 12 December 2014
Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
Fujiki R, Morita K, Sato M, Yamashita Y, Kato Y, Ishii Y, Shoji Y, Uchimura N
Neuropsychiatric Disease and Treatment 2014, 10:2353-2360
Published Date: 11 December 2014
Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
Kishi T, Matsunaga S, Matsuda Y, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:2339-2351
Published Date: 10 December 2014
Parkinson’s disease-associated melanin steal
Hinz M, Stein A, Cole T
Neuropsychiatric Disease and Treatment 2014, 10:2331-2337
Published Date: 10 December 2014
Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
Karthikeyan R, Marimuthu G, Ramasubramanian C, Arunachal G, BaHammam AS, Spence DW, Cardinali DP, Brown GM, Pandi-Perumal SR
Neuropsychiatric Disease and Treatment 2014, 10:2325-2330
Published Date: 9 December 2014
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study
Nishimura J, Kakeda S, Abe O, Yoshimura R, Watanabe K, Goto N, Hori H, Sato T, Takao H, Kabasawa H, Nakamura J, Korogi Y
Neuropsychiatric Disease and Treatment 2014, 10:2315-2323
Published Date: 8 December 2014
Remediation of context-processing deficits in schizophrenia: preliminary data with ambiguous sentences
Besche-Richard C, Terrien S, Lesgourgues M, Béchiri-Payet C, Gierski F, Limosin F
Neuropsychiatric Disease and Treatment 2014, 10:2307-2312
Published Date: 3 December 2014
Possible association between phantom vibration syndrome and occupational burnout
Chen CP, Wu CC, Chang LR, Lin YH
Neuropsychiatric Disease and Treatment 2014, 10:2307-2314
Published Date: 4 December 2014
Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
Amiri-Nikpour MR, Nazarbaghi S, Ahmadi-Salmasi B, Mokari T, Tahamtan U, Rezaei Y
Neuropsychiatric Disease and Treatment 2014, 10:2299-2306
Published Date: 3 December 2014
The clinical psychologist and the management of inpatient pain: a small case series
Childs SR, Casely EM, Kuehler BM, Ward S, Halmshaw CL, Thomas SE, Goodall ID, Bantel C
Neuropsychiatric Disease and Treatment 2014, 10:2291-2297
Published Date: 2 December 2014
Increasing dependency of older people in nursing homes is associated with need for dental treatments
Zenthöfer A, Rammelsberg P, Cabrera T, Hassel AJ
Neuropsychiatric Disease and Treatment 2014, 10:2285-2290
Published Date: 2 December 2014
Posttraumatic stress symptoms, dissociation, and alexithymia in an Italian sample of flood victims
Craparo G, Gori A, Mazzola E, Petruccelli I, Pellerone M, Rotondo G
Neuropsychiatric Disease and Treatment 2014, 10:2281-2284
Published Date: 28 November 2014
Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
Sharman J, Pennick M
Neuropsychiatric Disease and Treatment 2014, 10:2275-2280
Published Date: 28 November 2014
Cluster headache as a first manifestation of multiple sclerosis: case report and literature review
Mijajlović MD, Aleksić VM, Čovičković Šternić NM
Neuropsychiatric Disease and Treatment 2014, 10:2269-2274
Published Date: 25 November 2014
Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review
Guo YH, Kuan TS, Hsieh PC, Lien WC, Chang CK, Lin YC
Neuropsychiatric Disease and Treatment 2014, 10:2263-2267
Published Date: 24 November 2014
Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
Koppel J, Greenwald BS
Neuropsychiatric Disease and Treatment 2014, 10:2253-2262
Published Date: 24 November 2014
Foix-Chavany-Marie syndrome in a 17-year-old female with congenital cytomegalovirus infection
Conforti R, Capasso R, Capaldo G, Dato C, Saracino D, Di Iorio G, Melone MA
Neuropsychiatric Disease and Treatment 2014, 10:2249-2252
Published Date: 20 November 2014
Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation
Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Thabane L, Samaan Z
Neuropsychiatric Disease and Treatment 2014, 10:2239-2247
Published Date: 19 November 2014
A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis
Wang R, Zhang D, Zhao JZ, Wang S, Zhao YL, Niu HC
Neuropsychiatric Disease and Treatment 2014, 10:2231-2237
Published Date: 19 November 2014
Absent activation in medial prefrontal cortex and temporoparietal junction but not superior temporal sulcus during the perception of biological motion in schizophrenia: a functional MRI study
Hashimoto N, Toyomaki A, Hirai M, Miyamoto T, Narita H, Okubo R, Kusumi I
Neuropsychiatric Disease and Treatment 2014, 10:2221-2230
Published Date: 17 November 2014
Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome
Fonseca LM, Oliveira MC, Guilhoto LM, Cavalheiro EA, Bottino CM
Neuropsychiatric Disease and Treatment 2014, 10:2209-2219
Published Date: 17 November 2014
Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams
Dudova I, Markova D, Kasparova M, Zemankova J, Beranova S, Urbanek T, Hrdlicka M
Neuropsychiatric Disease and Treatment 2014, 10:2201-2208
Published Date: 17 November 2014
Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures
Cox JH, Seri S, Cavanna AE
Neuropsychiatric Disease and Treatment 2014, 10:2191-2200
Published Date: 14 November 2014
Epilepsy and violence: case series concerning physical trauma in children of persons with epilepsy
Gauffin H, Landtblom AM
Neuropsychiatric Disease and Treatment 2014, 10:2183-2189
Published Date: 14 November 2014
Below and beyond the recognition of emotional facial expressions in alcohol dependence: from basic perception to social cognition
D’Hondt F, Campanella S, Kornreich C, Philippot P, Maurage P
Neuropsychiatric Disease and Treatment 2014, 10:2177-2182
Published Date: 18 November 2014
Altered intrinsic regional brain spontaneous activity and subjective sleep quality in patients with chronic primary insomnia: a resting-state fMRI study
Dai XJ, Peng DC, Gong HH, Wan AL, Nie X, Li HJ, Wang YX
Neuropsychiatric Disease and Treatment 2014, 10:2163-2175
Published Date: 14 November 2014
Posttraumatic epilepsy: current and emerging treatment options
Paiva WS, Mello LE
Neuropsychiatric Disease and Treatment 2014, 10:2159-2161
Published Date: 13 November 2014
Decreased serum level of NGF in alcohol-dependent patients with declined executive function
Bae H, Ra Y, Han C, Kim DJ
Neuropsychiatric Disease and Treatment 2014, 10:2153-2157
Published Date: 13 November 2014
Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT
Aksay SS, Hausner L, Frölich L, Sartorius A
Neuropsychiatric Disease and Treatment 2014, 10:2147-2151
Published Date: 13 November 2014
Berberine exerts an anticonvulsant effect and ameliorates memory impairment and oxidative stress in a pilocarpine-induced epilepsy model in the rat
Gao F, Gao Y, Liu YF, Wang L, Li YJ
Neuropsychiatric Disease and Treatment 2014, 10:2139-2145
Published Date: 13 November 2014
Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis
Alfadhel M, Saleh N, Alenazi H, Baffoe-Bonnie H
Neuropsychiatric Disease and Treatment 2014, 10:2135-2137
Published Date: 12 November 2014
Association of BDNF Val66Met polymorphism with HPA and SAM axis reactivity to psychological and physical stress
Tsuru J, Tanaka Y, Ishitobi Y, Maruyama Y, Inoue A, Kawano A, Ikeda R, Ando T, Oshita H, Aizawa S, Masuda K, Higuma H, Kanehisa M, Ninomiya T, Akiyoshi J
Neuropsychiatric Disease and Treatment 2014, 10:2123-2133
Published Date: 11 November 2014
A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome
Harada T, Inada K, Yamada K, Sakamoto K, Ishigooka J
Neuropsychiatric Disease and Treatment 2014, 10:2115-2121
Published Date: 10 November 2014
Age-associated decrease in global DNA methylation in patients with major depression
Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY
Neuropsychiatric Disease and Treatment 2014, 10:2105-2114
Published Date: 10 November 2014
Psychiatric comorbidities in patients with major depressive disorder
Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S
Neuropsychiatric Disease and Treatment 2014, 10:2097-2103
Published Date: 10 November 2014
Iron deficiency and cognitive functions
Jáuregui-Lobera I
Neuropsychiatric Disease and Treatment 2014, 10:2087-2095
Published Date: 10 November 2014
Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?
Celik Guzel E, Bakkal E, Guzel S, Eroglu HE, Acar A, Kuçukyalcin V, Topcu B
Neuropsychiatric Disease and Treatment 2014, 10:2079-2086
Published Date: 5 November 2014
Intracranial malignant lesions correlate with the requirement for a long treatment course in postoperative central nervous system infection
Zhou H, Zhang XH
Neuropsychiatric Disease and Treatment 2014, 10:2071-2077
Published Date: 4 November 2014
EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
Asnis GM, Henderson MA
Neuropsychiatric Disease and Treatment 2014, 10:2069-2070
Published Date: 4 November 2014
Social cognition and its relationship to functional outcomes in patients with sustained acquired brain injury
Ubukata S, Tanemura R, Yoshizumi M, Sugihara G, Murai T, Ueda K
Neuropsychiatric Disease and Treatment 2014, 10:2061-2068
Published Date: 3 November 2014
Spinal cord demyelination combined with hyperhomocysteinemia: a case report
Hao MM, Zhang Y, Hou SX, Chen YL, Shi M, Zhao G, Deng YC
Neuropsychiatric Disease and Treatment 2014, 10:2057-2059
Published Date: 3 November 2014
Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM
Neuropsychiatric Disease and Treatment 2014, 10:2049-2055
Published Date: 31 October 2014
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
Coghill DR, Banaschewski T, Lecendreux M, Soutullo C, Zuddas A, Adeyi B, Sorooshian S
Neuropsychiatric Disease and Treatment 2014, 10:2039-2047
Published Date: 29 October 2014
Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study
Al Jumah K, Hassali MA, Al Qhatani D, El Tahir K
Neuropsychiatric Disease and Treatment 2014, 10:2031-2037
Published Date: 28 October 2014
Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options
Wang S, Fallah A
Neuropsychiatric Disease and Treatment 2014, 10:2021-2030
Published Date: 23 October 2014
Parental bonding and attitudes toward suicide among medical college students in Japan
Hashimoto K, Sugawara N, Tanaka O, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2014, 10:2015-2020
Published Date: 23 October 2014
Elongation of pulse width as an augmentation strategy in electroconvulsive therapy
Kawashima H, Suwa T, Murai T, Yoshioka R
Neuropsychiatric Disease and Treatment 2014, 10:2009-2014
Published Date: 23 October 2014
Nothing to smile about
Luca M, Luca A, Grasso CMAV, Calandra C
Neuropsychiatric Disease and Treatment 2014, 10:1999-2008
Published Date: 23 October 2014
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]
Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM
Neuropsychiatric Disease and Treatment 2014, 10:1997-1998
Published Date: 20 October 2014
Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry
Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M
Neuropsychiatric Disease and Treatment 2014, 10:1987-1996
Published Date: 20 October 2014
Long-term video EEG monitoring for diagnosis of psychogenic nonepileptic seizures
Gedzelman ER, LaRoche SM
Neuropsychiatric Disease and Treatment 2014, 10:1979-1986
Published Date: 15 October 2014
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, Shimizu T
Neuropsychiatric Disease and Treatment 2014, 10:1973-1978
Published Date: 15 October 2014
Cortisol levels and sleep patterns in infants with orofacial clefts undergoing surgery
Mueller AA, Kalak N, Schwenzer-Zimmerer K, Holsboer-Trachsler E, Brand S
Neuropsychiatric Disease and Treatment 2014, 10:1965-1972
Published Date: 15 October 2014
Neuropsychiatric symptoms and celiac disease
Urban-Kowalczyk M, Śmigielski J, Gmitrowicz A
Neuropsychiatric Disease and Treatment 2014, 10:1961-1964
Published Date: 14 October 2014
Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
Adam UU, Husain N, Haddad PM, Munshi T, Tariq F, Naeem F, Chaudhry IB
Neuropsychiatric Disease and Treatment 2014, 10:1953-1959
Published Date: 14 October 2014
Alexithymia in parents and adolescent anorexic daughters: comparing the responses to TSIA and TAS-20 scales
Balottin L, Nacinovich R, Bomba M, Mannarini S
Neuropsychiatric Disease and Treatment 2014, 10:1941-1951
Published Date: 9 October 2014
Violent victimization of adult patients with severe mental illness: a systematic review
Latalova K, Kamaradova D, Prasko J
Neuropsychiatric Disease and Treatment 2014, 10:1925-1939
Published Date: 9 October 2014
EMSAM (deprenyl patch): how a promising antidepressant was underutilized
Asnis GM, Henderson MA
Neuropsychiatric Disease and Treatment 2014, 10:1911-1923
Published Date: 6 October 2014
Diagnosing pseudobulbar affect in traumatic brain injury
Engelman W, Hammond FM, Malec JF
Neuropsychiatric Disease and Treatment 2014, 10:1903-1910
Published Date: 7 October 2014
Anxiety and depression levels in prepubertal obese children: a case-control study
Esposito M, Gallai B, Roccella M, Marotta R, Lavano F, Lavano SM, Mazzotta G, Bove D, Sorrentino M, Precenzano F, Carotenuto M
Neuropsychiatric Disease and Treatment 2014, 10:1897-1902
Published Date: 3 October 2014
Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease
Kim H, Lee KJ
Neuropsychiatric Disease and Treatment 2014, 10:1887-1896
Published Date: 3 October 2014
Prevalence of stress in junior doctors during their internship training: a cross-sectional study of three Saudi medical colleges’ hospitals
Abdulghani HM, Irshad M, Al Zunitan MA, Al Sulihem AA, Al Dehaim MA, Al Esefir WA, Al Rabiah AM, Kameshki RN, Alrowais NA, Sebiany A, Haque S
Neuropsychiatric Disease and Treatment 2014, 10:1879-1886
Published Date: 25 September 2014
Towards a framework for treatment effectiveness in schizophrenia
Juckel G, de Bartolomeis A, Gorwood P, Mosolov S, Pani L, Rossi A, Sanjuan J
Neuropsychiatric Disease and Treatment 2014, 10:1867-1878
Published Date: 24 September 2014
Early prediction of blonanserin response in Japanese patients with schizophrenia
Kishi T, Matsuda Y, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:1861-1866
Published Date: 23 September 2014
Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression
Luo J, Min S, Wei K, Cao J, Wang B, Li P, Dong J, Liu Y
Neuropsychiatric Disease and Treatment 2014, 10:1847-1859
Published Date: 23 September 2014
Development and validation of the Pictorial Cognitive Screening Inventory for illiterate people with dementia
Park S, Park SE, Kim MJ, Jung HY, Choi JS, Park KH, Kim I, Lee JY
Neuropsychiatric Disease and Treatment 2014, 10:1837-1845
Published Date: 23 September 2014
Kynurenine and depressive symptoms in a poststroke population
Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL
Neuropsychiatric Disease and Treatment 2014, 10:1827-1835
Published Date: 22 September 2014
Altered intrinsic regional brain activity in male patients with severe obstructive sleep apnea: a resting-state functional magnetic resonance imaging study
Peng DC, Dai XJ, Gong HH, Li HJ, Nie X, Zhang W
Neuropsychiatric Disease and Treatment 2014, 10:1819-1826
Published Date: 19 September 2014
A multidimensional risk factor model for suicide attempts in later life
Chan SMS, Chiu FKH, Lam CWL, Wong SMC, Conwell Y
Neuropsychiatric Disease and Treatment 2014, 10:1807-1817
Published Date: 18 September 2014
Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder
Lee HK, Jeong JH, Kim NY, Park MH, Kim TW, Seo HJ, Lim HK, Hong SC, Han JH
Neuropsychiatric Disease and Treatment 2014, 10:1799-1805
Published Date: 17 September 2014
Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K
Neuropsychiatric Disease and Treatment 2014, 10:1793-1798
Published Date: 18 September 2014
Attention-deficit/hyperactivity disorder in postsecondary students
Nugent K, Smart W
Neuropsychiatric Disease and Treatment 2014, 10:1781-1791
Published Date: 26 September 2014
Modulation of the GABAergic pathway for the treatment of fragile X syndrome
Lozano R, Hare EB, Hagerman RJ
Neuropsychiatric Disease and Treatment 2014, 10:1769-1779
Published Date: 16 September 2014
Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome
Ohara N, Suzuki H, Suzuki A, Kaneko M, Ishizawa M, Furukawa K, Abe T, Matsubayashi Y, Yamada T, Hanyu O, Shimohata T, Sone H
Neuropsychiatric Disease and Treatment 2014, 10:1763-1767
Published Date: 15 September 2014
No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: 1H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex
Bajs Janović M, Kalember P, Janović Š, Hrabač P, Folnegović Grošić P, Grošić V, Radoš M, Henigsberg N
Neuropsychiatric Disease and Treatment 2014, 10:1753-1762
Published Date: 17 September 2014
Cognitive assessments for the early diagnosis of dementia after stroke
Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S
Neuropsychiatric Disease and Treatment 2014, 10:1743-1751
Published Date: 12 September 2014
Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions
Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T
Neuropsychiatric Disease and Treatment 2014, 10:1727-1742
Published Date: 12 September 2014
The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
Ishioka M, Sugawara N, Kaneda A, Okubo N, Iwane K, Takahashi I, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2014, 10:1721-1725
Published Date: 11 September 2014
Association between smoking and cognitive impairment in multiple sclerosis
Özcan ME, İnce B, Bingöl A, Ertürk S, Altınöz MA, Karadeli HH, Koçer A, Asil T
Neuropsychiatric Disease and Treatment 2014, 10:1715-1719
Published Date: 10 September 2014
Validity and clinical utilization of the Chinese version of the Gotland Male Depression Scale at a men’s health polyclinic
Chu CL, Chen Y, Jiang KH, Chen JL, Lee CP, Chau YL, Chen CY
Neuropsychiatric Disease and Treatment 2014, 10:1707-1714
Published Date: 10 September 2014
Animal models of epilepsy: use and limitations
Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP
Neuropsychiatric Disease and Treatment 2014, 10:1693-1705
Published Date: 9 September 2014
Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment
Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S, Mohamad K
Neuropsychiatric Disease and Treatment 2014, 10:1677-1691
Published Date: 9 September 2014
Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder
Türksoy N, Bilici R, Yalçıner A, Özdemir YÖ, Örnek I, Tufan AE, Kara A
Neuropsychiatric Disease and Treatment 2014, 10:1671-1675
Published Date: 9 September 2014
Decreased mean platelet volume in panic disorder
Göğçegöz Gül I, Eryılmaz G, Özten E, Hızlı Sayar G
Neuropsychiatric Disease and Treatment 2014, 10:1665-1669
Published Date: 4 September 2014
Recognition of facial expressions by alcoholic patients: a systematic literature review
Donadon MF, Osório FL
Neuropsychiatric Disease and Treatment 2014, 10:1655-1663
Published Date: 5 September 2014
Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents
Duric NS, Aßmus J, Elgen IB
Neuropsychiatric Disease and Treatment 2014, 10:1645-1654
Published Date: 2 September 2014
Risk of epilepsy in patients with systemic lupus erythematosus – a retrospective cohort study
Tsai JD, Lin CL, Lin CC, Sung FC, Lue KH
Neuropsychiatric Disease and Treatment 2014, 10:1635-1643
Published Date: 2 September 2014
Yokukansan and its ingredients as possible treatment options for schizophrenia
Yu CH, Ishii R, Yu SC, Takeda M
Neuropsychiatric Disease and Treatment 2014, 10:1629-1634
Published Date: 1 September 2014
A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K
Neuropsychiatric Disease and Treatment 2014, 10:1621-1627
Published Date: 30 August 2014
Aggression, impulsivity, and suicide risk in benign chronic pain patients – a cross-sectional study
Margari F, Lorusso M, Matera E, Pastore A, Zagaria G, Bruno F, Puntillo F, Margari L
Neuropsychiatric Disease and Treatment 2014, 10:1613-1620
Published Date: 2 September 2014
Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU
Neuropsychiatric Disease and Treatment 2014, 10:1605-1611
Published Date: 30 August 2014
Motivation for treatment in patients with substance use disorder: personal volunteering versus legal/familial enforcement
Bilici R, Yazici E, Tufan AE, Mutlu E, İzci F, Ugurlu GK
Neuropsychiatric Disease and Treatment 2014, 10:1599-1604
Published Date: 30 August 2014
The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
Findling RL, Ginsberg LD
Neuropsychiatric Disease and Treatment 2014, 10:1589-1597
Published Date: 27 August 2014
Hepatotoxicity induced by clozapine: a case report and review of literature
Wu Chou AI, Lu ML, Shen WW
Neuropsychiatric Disease and Treatment 2014, 10:1585-1587
Published Date: 26 August 2014
Influence of patient characteristics on care time in patients hospitalized with schizophrenia
Sugibayashi Y, Yoshimura K, Yamauchi K, Inagaki A, Ikegami N
Neuropsychiatric Disease and Treatment 2014, 10:1577-1584
Published Date: 25 August 2014
The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
Hashimoto K, Sugawara N, Ishioka M, Nakamura K, Yasui-Furukori N
Neuropsychiatric Disease and Treatment 2014, 10:1571-1576
Published Date: 22 August 2014
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
Gajria K, Lu M, Sikirica V, Greven P, Zhong Y, Qin P, Xie J
Neuropsychiatric Disease and Treatment 2014, 10:1543-1569
Published Date: 22 August 2014
Clinical utility of the Chinese Strengths and Weaknesses of ADHD-Symptoms and Normal-behaviors questionnaire (SWAN) when compared with DISC-IV
Chan GFC, Lai KYC, Luk ESL, Hung SF, Leung PWL
Neuropsychiatric Disease and Treatment 2014, 10:1533-1542
Published Date: 21 August 2014
Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure
Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant’Anna M, Kawamoto SY, Galvão E, Parker G, Fleck MP
Neuropsychiatric Disease and Treatment 2014, 10:1523-1531
Published Date: 19 August 2014
Diagnostic and therapeutic utility of neuroimaging in depression: an overview
Wise T, Cleare AJ, Herane A, Young AH, Arnone D
Neuropsychiatric Disease and Treatment 2014, 10:1509-1522
Published Date: 19 August 2014
Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study
Samaan Z, Bawor M, Dennis BB, Plater C, Varenbut M, Daiter J, Worster A, Marsh DC, Tan C, Desai D, Thabane L, Pare G
Neuropsychiatric Disease and Treatment 2014, 10:1503-1508
Published Date: 19 August 2014
Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version
Waleeprakhon P, Ittasakul P, Lotrakul M, Wisajun P, Jullagate S, Ketter TA
Neuropsychiatric Disease and Treatment 2014, 10:1497-1502
Published Date: 18 August 2014
Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro
Gao F, Liu Z, Ren W, Jiang W
Neuropsychiatric Disease and Treatment 2014, 10:1489-1495
Published Date: 16 August 2014
A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services
Di Lorenzo R, Galliani A, Guicciardi A, Landi G, Ferri P
Neuropsychiatric Disease and Treatment 2014, 10:1479-1488
Published Date: 11 August 2014
Post-traumatic epilepsy: current and emerging treatment options
Szaflarski JP, Nazzal Y, Dreer LE
Neuropsychiatric Disease and Treatment 2014, 10:1469-1477
Published Date: 11 August 2014
Probing smoking craving with a multidimensional approach: validation of the 12-item French-language version of the Questionnaire on Smoking Urges
Dethier V, Heeren A, Galanti L, Philippot P, Billieux J
Neuropsychiatric Disease and Treatment 2014, 10:1459-1468
Published Date: 7 August 2014
High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke
Kara H, Akinci M, Degirmenci S, Bayir A, Ak A, Nayman A, Unlu A, Akyurek F, Sivri M
Neuropsychiatric Disease and Treatment 2014, 10:1451-1457
Published Date: 6 August 2014
A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
Maneeton N, Maneeton B, Intaprasert S, Woottiluk P
Neuropsychiatric Disease and Treatment 2014, 10:1439-1449
Published Date: 1 August 2014
Examining the relationship between adherence and satisfaction with antidepressant treatment
Aljumah K, Ahmad Hassali A, AlQhatani S
Neuropsychiatric Disease and Treatment 2014, 10:1433-1438
Published Date: 4 August 2014
Sleep quality changes in insomniacs and non-insomniacs after acute altitude exposure and its relationship with acute mountain sickness
Tang XG, Zhang JH, Gao XB, Li QN, Li JB, Yu J, Qin J, Huang L
Neuropsychiatric Disease and Treatment 2014, 10:1423-1432
Published Date: 31 July 2014
The relationship between insight and subjective experience in schizophrenia
Kako Y, Ito K, Hashimoto N, Toyoshima K, Shimizu Y, Mitsui N, Fujii Y, Tanaka T, Kusumi I
Neuropsychiatric Disease and Treatment 2014, 10:1415-1422
Published Date: 29 July 2014
Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease
Iavarone A, Ziello AR, Pastore F, Fasanaro AM, Poderico C
Neuropsychiatric Disease and Treatment 2014, 10:1407-1413
Published Date: 29 July 2014
Perspectives on perceived stigma and self-stigma in adult male patients with depression
Latalova K, Kamaradova D, Prasko J
Neuropsychiatric Disease and Treatment 2014, 10:1399-1405
Published Date: 29 July 2014
Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
Lee BH, Park YM, Um TH, Kim S
Neuropsychiatric Disease and Treatment 2014, 10:1393-1398
Published Date: 23 July 2014
Cognitive dysfunction in pediatric multiple sclerosis
Suppiej A, Cainelli E
Neuropsychiatric Disease and Treatment 2014, 10:1385-1392
Published Date: 23 July 2014
Cerebellar dysregulation and heterogeneity of mood disorders
Tobe EH
Neuropsychiatric Disease and Treatment 2014, 10:1381-1384
Published Date: 23 July 2014
Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
McDevitt RA, Reed SJ, Britt JP
Neuropsychiatric Disease and Treatment 2014, 10:1369-1379
Published Date: 22 July 2014
The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
Wu X, Huang Z, Han H, Zhong Z, Gan Z, Guo X, Diao F, Han Z, Zhao J
Neuropsychiatric Disease and Treatment 2014, 10:1361-1368
Published Date: 22 July 2014
Reduced brain resting-state network specificity in infants compared with adults
Wylie KP, Rojas DC, Ross RG, Hunter SK, Maharajh K, Cornier M-A, Tregellas JR
Neuropsychiatric Disease and Treatment 2014, 10:1349-1359
Published Date: 21 July 2014
Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature
Harris PR, Sommargren CE, Stein PK, Fung GL, Drew BJ
Neuropsychiatric Disease and Treatment 2014, 10:1335-1347
Published Date: 18 July 2014
A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]
Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY
Neuropsychiatric Disease and Treatment 2014, 10:1333-1334
Published Date: 18 July 2014
Dimensional assessment of DSM-5 social anxiety symptoms among university students and its relationship with functional impairment
Dell’Osso L, Abelli M, Pini S, Carlini M, Carpita B, Macchi E, Gorrasi F, Mengali F, Tognetti R, Massimetti G
Neuropsychiatric Disease and Treatment 2014, 10:1325-1332
Published Date: 16 July 2014
Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
Zhu W, Zhang Z, Qi J, Liu F, Chen J, Zhao J, Guo X
Neuropsychiatric Disease and Treatment 2014, 10:1317-1323
Published Date: 14 July 2014
Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia
Vlcek P, Bob P, Raboch J
Neuropsychiatric Disease and Treatment 2014, 10:1309-1315
Published Date: 14 July 2014
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
Alvarez E, Perez V, Artigas F
Neuropsychiatric Disease and Treatment 2014, 10:1297-1307
Published Date: 15 July 2014
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?
Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H
Neuropsychiatric Disease and Treatment 2014, 10:1287-1296
Published Date: 10 July 2014
Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease
Pereira ML, Camargo MVZA, Aprahamian I, Forlenza OV
Neuropsychiatric Disease and Treatment 2014, 10:1273-1285
Published Date: 9 July 2014
Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors
El-Tallawy HN, Farghaly WMA, Shehata GA, Rageh TA, Metwally NA, Badry R, Sayed MAM, Abd El Hamed M, Abd-Elwarth A, Kandil MR
Neuropsychiatric Disease and Treatment 2014, 10:1267-1272
Published Date: 8 July 2014
Apotemnophilia, body integrity identity disorder or xenomelia? Psychiatric and neurologic etiologies face each other
Sedda A, Bottini G
Neuropsychiatric Disease and Treatment 2014, 10:1255-1265
Published Date: 7 July 2014
The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
Grošić V, Folnegović Grošić P, Kalember P, Bajs Janović M, Radoš M, Mihanović M, Henigsberg N
Neuropsychiatric Disease and Treatment 2014, 10:1243-1253
Published Date: 7 July 2014
Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure
Wang LJ, Chen CK, Hsu HJ, Wu IW, Sun CY, Lee CC
Neuropsychiatric Disease and Treatment 2014, 10:1235-1241
Published Date: 5 July 2014
Investigation of health anxiety and its related factors in nursing students
Zhang Y, Zhao Y, Mao S, Li G, Yuan Y
Neuropsychiatric Disease and Treatment 2014, 10:1223-1234
Published Date: 7 July 2014
Quantification of functional abilities in Rett syndrome: a comparison between stages III and IV
Monteiro CBM, Savelsbergh GJP, Smorenburg ARP, Graciani Z, Torriani-Pasin C, de Abreu LC, Valenti VE, Kok F
Neuropsychiatric Disease and Treatment 2014, 10:1213-1222
Published Date: 3 July 2014
The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study
Yasui-Furukori N, Kikuchi A, Katagai H, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:1209-1212
Published Date: 3 July 2014
Sleep duration and subjective psychological well-being in adolescence: a longitudinal study in Switzerland and Norway
Kalak N, Lemola S, Brand S, Holsboer–Trachsler E, Grob A
Neuropsychiatric Disease and Treatment 2014, 10:1199-1207
Published Date: 3 July 2014
The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F
Neuropsychiatric Disease and Treatment 2014, 10:1191-1197
Published Date: 28 June 2014
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:1183-1190
Published Date: 25 June 2014
Brain meningioma with initial manifestation similar to cervical radiculopathy: a case report
Huang YH, Hong CZ, Wu WT, Li KT, Chou LW
Neuropsychiatric Disease and Treatment 2014, 10:1175-1181
Published Date: 25 June 2014
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
Schoedel KA, Morrow SA, Sellers EM
Neuropsychiatric Disease and Treatment 2014, 10:1161-1174
Published Date: 26 June 2014
Improvement of verbal fluency in patients with diffuse brain injury over time
Zaninotto AL, Guirado VM, Baldivia B, Núñez MD, Amorim RL, Teixeira MJ, Lucia MC, Andrade AF, Paiva WS
Neuropsychiatric Disease and Treatment 2014, 10:1155-1160
Published Date: 24 June 2014
A failure to confirm the effectiveness of a brief group psychoeducational program for mothers of children with high-functioning pervasive developmental disorders: a randomized controlled pilot trial
Suzuki M, Yamada A, Watanabe N, Akechi T, Katsuki F, Nishiyama T, Imaeda M, Miyachi T, Otaki K, Mitsuda Y, Ota A, Furukawa TA
Neuropsychiatric Disease and Treatment 2014, 10:1141-1153
Published Date: 30 June 2014
Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis
Pan YQ, Yao J, Wang BJ
Neuropsychiatric Disease and Treatment 2014, 10:1133-1139
Published Date: 20 June 2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Neuropsychiatric Disease and Treatment 2014, 10:1125-1131
Published Date: 20 June 2014
Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients
Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T
Neuropsychiatric Disease and Treatment 2014, 10:1113-1124
Published Date: 18 June 2014
Profile of minocycline and its potential in the treatment of schizophrenia
Zhang L, Zhao J
Neuropsychiatric Disease and Treatment 2014, 10:1103-1111
Published Date: 17 June 2014
Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders
Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A
Neuropsychiatric Disease and Treatment 2014, 10:1093-1101
Published Date: 17 June 2014
Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder
Montoya A, Hervás A, Fuentes J, Cardo E, Polavieja P, Quintero J, Tannock R
Neuropsychiatric Disease and Treatment 2014, 10:1081-1092
Published Date: 13 June 2014
Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms
Lozano R, Marín R, Freire I, Santacruz MJ, Pascual-García A
Neuropsychiatric Disease and Treatment 2014, 10:1079-1080
Published Date: 12 June 2014
Tackling nonadherence in psychiatric disorders: current opinion
Farooq S, Naeem F
Neuropsychiatric Disease and Treatment 2014, 10:1069-1077
Published Date: 12 June 2014
Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey
van der Feltz-Cornelis CM, van Os J, Knappe S, Schumann G, Vieta E, Wittchen HU, Lewis SW, Elfeddali I, Wahlbeck K, Linszen D, Obradors-Tarragó C, Haro JM
Neuropsychiatric Disease and Treatment 2014, 10:1057-1068
Published Date: 27 June 2014
Frontotemporal dementia and primary progressive aphasia, a review
Kirshner HS
Neuropsychiatric Disease and Treatment 2014, 10:1045-1055
Published Date: 12 June 2014
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report
De Pasquale C, Pistorio ML, Veroux M, Giaquinta A, Veroux P, Fornaro M
Neuropsychiatric Disease and Treatment 2014, 10:1039-1044
Published Date: 11 June 2014
Neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials
Petit G, Cimochowska A, Kornreich C, Hanak C, Verbanck P, Campanella S
Neuropsychiatric Disease and Treatment 2014, 10:1025-1037
Published Date: 9 June 2014
Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms
Park CM, Seo HJ, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH, Hur MH, Song JM
Neuropsychiatric Disease and Treatment 2014, 10:1017-1023
Published Date: 9 June 2014
A new method for analyzing auditory brain-stem response waveforms using a moving-minimum subtraction procedure of digitized analog recordings
Källstrand J, Lewander T, Baghdassarian E, Nielzén S
Neuropsychiatric Disease and Treatment 2014, 10:1011-1016
Published Date: 6 June 2014
Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy
Moretti DV, Binetti G, Zanetti O, Frisoni GB
Neuropsychiatric Disease and Treatment 2014, 10:1003-1009
Published Date: 5 June 2014
Perceiving “ghost” images: a unique case of visual allesthesia with hemianopsia in mitochondrial disease
Murakami H, Ichikawa H, Sugimoto A, Futamura A, Shimizu Y, Sugie M, Miller MW, Kawamura M
Neuropsychiatric Disease and Treatment 2014, 10:999-1002
Published Date: 5 June 2014
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:997-998
Published Date: 5 June 2014
Determining a diagnostic cut-off on the Teate Depression Inventory
Balsamo M, Saggino A
Neuropsychiatric Disease and Treatment 2014, 10:987-995
Published Date: 3 June 2014
Effect of calligraphy training on hyperarousal symptoms for childhood survivors of the 2008 China earthquakes
Zhu Z, Wang R, Kao HSR, Zong Y, Liu Z, Tang S, Xu M, Liu ICY, Lam SPW
Neuropsychiatric Disease and Treatment 2014, 10:977-985
Published Date: 3 June 2014
Epileptic and cognitive changes in children with cerebral palsy: an Egyptian study
El-Tallawy HN, Farghaly WMA, Shehata GA, Badry R, Rageh TA
Neuropsychiatric Disease and Treatment 2014, 10:971-975
Published Date: 29 May 2014
Two cases of emotional disorder after middle cerebral artery infarction showing distinct responses to antidepressant treatment
Shimoda K, Kimura M
Neuropsychiatric Disease and Treatment 2014, 10:965-970
Published Date: 23 May 2014
Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process
Anzellotti F, Franciotti R, Zhuzhuni H, D’Amico A, Thomas A, Onofrj M
Neuropsychiatric Disease and Treatment 2014, 10:959-964
Published Date: 23 May 2014
Possible association between vitamin D deficiency and restless legs syndrome
Oran M, Unsal C, Albayrak Y, Tulubas F, Oguz K, Avci O, Turgut N, Alp R, Gurel A
Neuropsychiatric Disease and Treatment 2014, 10:953-958
Published Date: 21 May 2014
Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
Samtani MN, Raghavan N, Novak G, Nandy P, Narayan VA
Neuropsychiatric Disease and Treatment 2014, 10:929-952
Published Date: 24 May 2014
Social support networks and eating disorders: an integrative review of the literature
Leonidas C, Santos MA
Neuropsychiatric Disease and Treatment 2014, 10:915-927
Published Date: 21 May 2014
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
Fornaro M, Bandini F, Cestari L, Cordano C, Ogliastro C, Albano C, De Berardis D, Martino M, Escelsior A, Rocchi G, Fornaro P, De Pasquale C
Neuropsychiatric Disease and Treatment 2014, 10:907-914
Published Date: 20 May 2014
Neuropathic sensory symptoms: association with pain and psychological factors
Shaygan M, Böger A, Kröner-Herwig B
Neuropsychiatric Disease and Treatment 2014, 10:897-906
Published Date: 20 May 2014
Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder
Coles T, Coon C, DeMuro C, McLeod L, Gnanasakthy A
Neuropsychiatric Disease and Treatment 2014, 10:887-895
Published Date: 19 May 2014
Temperament, character traits, and alexithymia in patients with panic disorder
Izci F, Gültekin BK, Saglam S, Koc MI, Zincir SB, Atmaca M
Neuropsychiatric Disease and Treatment 2014, 10:879-885
Published Date: 16 May 2014
Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People’s Republic of China
Ye W, Montgomery W, Kadziola Z, Liu L, Xue H, Stensland MD, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:869-878
Published Date: 16 May 2014
Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A
Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S
Neuropsychiatric Disease and Treatment 2014, 10:865-867
Published Date: 16 May 2014
Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
Xue HBH, Liu L, Zhang H, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:841-864
Published Date: 16 May 2014
Nerve growth factor variations in patients with mood disorders: no changes in eight weeks of clinical treatment
Liu X, Zhang T, He S, Hong B, Peng D, Su H, Li F, Tang Y, Lin Z, Fang Y, Jiang K
Neuropsychiatric Disease and Treatment 2014, 10:835-840
Published Date: 15 May 2014
Social phobia in Parkinson’s disease: Prevalence and risk factors
Gultekin BK, Ozdilek B, Bestepe EE
Neuropsychiatric Disease and Treatment 2014, 10:829-834
Published Date: 21 May 2014
Latent class analysis on internet and smartphone addiction in college students
Mok JY, Choi SW, Kim DJ, Choi JS, Lee J, Ahn H, Choi EJ, Song WY
Neuropsychiatric Disease and Treatment 2014, 10:817-828
Published Date: 20 May 2014
The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder
Mitsui N, Asakura S, Shimizu Y, Fujii Y, Toyomaki A, Kako Y, Tanaka T, Kitagawa N, Inoue T, Kusumi I
Neuropsychiatric Disease and Treatment 2014, 10:811-816
Published Date: 15 May 2014
Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry
Paholpak S, Kongsakon R, Pattanakumjorn W, Kanokvut R, Wongsuriyadech W, Srisurapanont M
Neuropsychiatric Disease and Treatment 2014, 10:803-810
Published Date: 15 May 2014
Factors associated with body image distortion in Korean adolescents
Hyun MY, Jung YE, Kim MD, Kwak YS, Hong SC, Bahk WM, Yoon BH, Yoon HW, Yoo B
Neuropsychiatric Disease and Treatment 2014, 10:797-802
Published Date: 13 May 2014
The prevalence of bipolar spectrum disorder in elderly patients with recurrent depression
Lee CI, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH
Neuropsychiatric Disease and Treatment 2014, 10:791-795
Published Date: 8 May 2014
Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
Chue P, Lalonde JK
Neuropsychiatric Disease and Treatment 2014, 10:777-789
Published Date: 8 May 2014
Nonergot dopamine-receptor agonists for treating Parkinson's disease – a network meta-analysis
Thorlund K, Wu P, Druyts E, Eapen S, Mills EJ
Neuropsychiatric Disease and Treatment 2014, 10:767-776
Published Date: 7 May 2014
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
Gobbi G, Comai S, Debonnel G
Neuropsychiatric Disease and Treatment 2014, 10:757-765
Published Date: 7 May 2014
More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997–2013
Kedzior KK, Azorina V, Reitz SK
Neuropsychiatric Disease and Treatment 2014, 10:727-756
Published Date: 7 May 2014
Psychiatry 2050: from younger psychiatrists' perspective
Hassan TM, Habib W, Mazhar MN, Munshi T
Neuropsychiatric Disease and Treatment 2014, 10:723-726
Published Date: 7 May 2014
Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:719-722
Published Date: 5 May 2014
Methods of suicide predict the risks and method-switching of subsequent suicide attempts: a community cohort study in Taiwan
Huang YC, Wu YW, Chen CK, Wang LJ
Neuropsychiatric Disease and Treatment 2014, 10:711-718
Published Date: 5 May 2014
Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia
Dietrich-Muszalska A, Kwiatkowska A
Neuropsychiatric Disease and Treatment 2014, 10:703-709
Published Date: 5 May 2014
Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty
Coelho F, Oliveira AM, Paiva WS, Freire FR, Calado VT, Amorim RL, Neville IS, Andrade AF, Bor-Seng-Shu E, Anghinah R, Teixeira MJ
Neuropsychiatric Disease and Treatment 2014, 10:695-701
Published Date: 2 May 2014
Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
Beyazyüz M, Albayrak Y, Beyazyüz E, Ünsal C, Göka E
Neuropsychiatric Disease and Treatment 2014, 10:687-693
Published Date: 29 April 2014
Solitary skull metastasis as the first symptom of hepatocellular carcinoma: case report and literature review
Guo X, Yin J, Jiang Y
Neuropsychiatric Disease and Treatment 2014, 10:681-686
Published Date: 28 April 2014
Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression
Bizik G, Bob P, Raboch J, Pavlat J, Uhrova J, Benakova H, Zima T
Neuropsychiatric Disease and Treatment 2014, 10:675-679
Published Date: 25 April 2014
Letter to the editor regarding "Study design of 'Friends for Life': a process and effect evaluation of an indicated school-based prevention program": response to Lima et al
Kösters MP, Chinapaw MJ, Zwaanswijk M, van der Wal MF, Koot HM
Neuropsychiatric Disease and Treatment 2014, 10:671-674
Published Date: 23 April 2014
Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study
Seo HJ, Choi YH, Chung YA, Rho W, Chae JH
Neuropsychiatric Disease and Treatment 2014, 10:661-669
Published Date: 17 April 2014
Spatial memory impairments in amnestic mild cognitive impairment in a virtual radial arm maze
Lee JY, Kho S, Yoo HB, Park S, Choi JS, Kwon JS, Cha KR, Jung HY
Neuropsychiatric Disease and Treatment 2014, 10:653-660
Published Date: 17 April 2014
Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population
Yao J, Ding M, Xing JX, Xuan JF, Pang H, Pan YQ, Wang BJ
Neuropsychiatric Disease and Treatment 2014, 10:645-652
Published Date: 17 April 2014
A case report of suicidal behavior related to subclinical hyperthyroidism
Joo SH, Jeong JH, Hong SC
Neuropsychiatric Disease and Treatment 2014, 10:641-643
Published Date: 17 April 2014
Agomelatine in the treatment of depressive disorders in clinical practice: multicenter observational CHRONOS study
Ivanov SV, Samushiya MA
Neuropsychiatric Disease and Treatment 2014, 10:631-639
Published Date: 17 April 2014
Suicidal ideation and the risk of suicide in patients with fibromyalgia: a comparison with non-pain controls and patients suffering from low-back pain
Jimenez-Rodriguez I, Garcia-Leiva JM, Jimenez-Rodriguez BM, Condés-Moreno E, Rico-Villademoros F, Calandre EP
Neuropsychiatric Disease and Treatment 2014, 10:625-630
Published Date: 16 April 2014
Proposed criteria for schizophrenia remission
AlAqeel B
Neuropsychiatric Disease and Treatment 2014, 10:619-623
Published Date: 16 April 2014
Analysis of cardiac autonomic modulation of children with attention deficit hyperactivity disorder
de Carvalho TD, Wajnsztejn R, de Abreu LC, Marques Vanderlei LC, Godoy MF, Adami F, Valenti VE, Monteiro CBM, Leone C, da Cruz Martins KC, Ferreira C
Neuropsychiatric Disease and Treatment 2014, 10:613-618
Published Date: 11 April 2014
Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson's disease: a case report
Zhang HW, Wang YY, Liang JC, Förster S, Wu P, Zhao J, Guan YH, Zuo CT
Neuropsychiatric Disease and Treatment 2014, 10:607-611
Published Date: 8 April 2014
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:599-606
Published Date: 8 April 2014
Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
Mauger S, Fraser R, Gill K
Neuropsychiatric Disease and Treatment 2014, 10:587-598
Published Date: 7 April 2014
Exploratory study describing 6 month outcomes for young children with autism who receive treatment as usual in Italy
Muratori F, Narzisi A
Neuropsychiatric Disease and Treatment 2014, 10:577-586
Published Date: 8 April 2014
Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment
Lawson VH, Arnold WD
Neuropsychiatric Disease and Treatment 2014, 10:567-576
Published Date: 5 April 2014
Chorea disclosing a polycythemia vera
Liu GD, Chang J, Liu ZJ, Qiang Q, Gu CH, Zhang YY, Wei WS
Neuropsychiatric Disease and Treatment 2014, 10:563-565
Published Date: 5 April 2014
Effectiveness of methylphenidate as augmentation therapy after failure of adjunctive neuromodulation for patients with treatment-refractory bipolar depression: a case report
Adida M, Azorin JM
Neuropsychiatric Disease and Treatment 2014, 10:559-562
Published Date: 2 April 2014
Anterior capsulotomy improves persistent developmental stuttering with a psychiatric disorder: a case report and literature review
Zhang SZ, Li P, Zhang ZJ, Wang W
Neuropsychiatric Disease and Treatment 2014, 10:553-558
Published Date: 1 April 2014
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
Rizzoli PB
Neuropsychiatric Disease and Treatment 2014, 10:547-552
Published Date: 31 March 2014
Suicidal behavior among Turkish patients with Parkinson’s disease
Ozdilek B, Gultekin BK
Neuropsychiatric Disease and Treatment 2014, 10:541-545
Published Date: 26 March 2014
A cross-sectional study on perception of stigma by Chinese schizophrenia patients
Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY
Neuropsychiatric Disease and Treatment 2014, 10:535-540
Published Date: 26 March 2014
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:527-533
Published Date: 26 March 2014
Prevalence of depression and its relationship with work characteristics in a sample of public workers
Luca M, Bellia S, Bellia M, Luca A, Calandra C
Neuropsychiatric Disease and Treatment 2014, 10:519-525
Published Date: 25 March 2014
Neuropsychological phenotype of a patient with a de novo 970 kb interstitial deletion in the distal 16p11.2 region
Egger JI, Verhoeven WM, Verbeeck W, de Leeuw N
Neuropsychiatric Disease and Treatment 2014, 10:513-517
Published Date: 25 March 2014
Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report
Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa SI, Yabe H
Neuropsychiatric Disease and Treatment 2014, 10:507-511
Published Date: 25 March 2014
A novel five-category multimodal T1-weighted and T2-weighted magnetic resonance imaging-based stratification system for the selection of spinal arachnoid cyst treatment: a 15-year experience of 81 cases
Qi J, Yang J, Wang GH
Neuropsychiatric Disease and Treatment 2014, 10:499-506
Published Date: 19 March 2014
Update on once-daily zonisamide monotherapy in partial seizures
Afra P, Adamolekun B
Neuropsychiatric Disease and Treatment 2014, 10:493-498
Published Date: 19 March 2014
Dissociation in schizophrenia and borderline personality disorder
Pec O, Bob P, Raboch J
Neuropsychiatric Disease and Treatment 2014, 10:487-491
Published Date: 17 March 2014
Improvement of gross motor and cognitive abilities by an exercise training program: three case reports
Alesi M, Battaglia G, Roccella M, Testa D, Palma A, Pepi A
Neuropsychiatric Disease and Treatment 2014, 10:479-485
Published Date: 14 March 2014
Reliability and validity of the Thai version of the Yale–Brown Obsessive Compulsive Scale – Second Edition in clinical samples
Hiranyatheb T, Saipanish R, Lotrakul M
Neuropsychiatric Disease and Treatment 2014, 10:471-477
Published Date: 13 March 2014
When to start aripiprazole therapy in patients with bipolar mania
Sayyaparaju KK, Grunze H, Fountoulakis KN
Neuropsychiatric Disease and Treatment 2014, 10:459-470
Published Date: 13 March 2014
Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders
Kittirattanapaiboon P, Suttajit S, Junsirimongkol B, Likhitsathian S, Srisurapanont M
Neuropsychiatric Disease and Treatment 2014, 10:453-458
Published Date: 13 March 2014
Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease
Fan LY, Chiu MJ
Neuropsychiatric Disease and Treatment 2014, 10:439-451
Published Date: 11 March 2014
Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients
Hızlı Sayar G, Eryılmaz G, Şemieoğlu S, Özten E, Göğcegöz Gül I
Neuropsychiatric Disease and Treatment 2014, 10:433-438
Published Date: 4 March 2014
Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:427-432
Published Date: 28 February 2014
Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the electronic Schizophrenia Treatment Adherence Registry in Canada
Williams R, Chandrasena R, Beauclair L, Luong D, Lam A
Neuropsychiatric Disease and Treatment 2014, 10:417-425
Published Date: 27 February 2014
Long-term efficacy and safety of iloperidone: an update
Rado JT, Janicak PG
Neuropsychiatric Disease and Treatment 2014, 10:409-415
Published Date: 26 February 2014
A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase
Nisijima K, Shioda K
Neuropsychiatric Disease and Treatment 2014, 10:403-407
Published Date: 24 February 2014
Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease
Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM
Neuropsychiatric Disease and Treatment 2014, 10:391-401
Published Date: 21 February 2014
Comparison of anesthetics in electroconvulsive therapy: an effective treatment with the use of propofol, etomidate, and thiopental
Zahavi GS, Dannon P
Neuropsychiatric Disease and Treatment 2014, 10:383-389
Published Date: 20 February 2014
What’s in the pipeline? Drugs in development for autism spectrum disorder
Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, Weng SJ
Neuropsychiatric Disease and Treatment 2014, 10:371-381
Published Date: 20 February 2014
Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery
Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA
Neuropsychiatric Disease and Treatment 2014, 10:361-370
Published Date: 19 February 2014
Clinical utility of orally disintegrating olanzapine in Chinese patients with schizophrenia: a review of effectiveness, patient preference, adherence, and other properties
Zhao J, Ou J, Xue H, Liu L, Montgomery W, Treuer T
Neuropsychiatric Disease and Treatment 2014, 10:355-359
Published Date: 19 February 2014
New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
Katona CL, Katona CP
Neuropsychiatric Disease and Treatment 2014, 10:349-354
Published Date: 19 February 2014
Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease
Banno K, Nakaaki S, Sato J, Torii K, Narumoto J, Miyata J, Hirono N, Furukawa TA, Mimura M, Akechi T
Neuropsychiatric Disease and Treatment 2014, 10:339-348
Published Date: 17 February 2014
Psychological morbidity, quality of life, and self-rated health in the military personnel
Chou HW, Tzeng WC, Chou YC, Yeh HW, Chang HA, Kao YC, Tzeng NS
Neuropsychiatric Disease and Treatment 2014, 10:329-338
Published Date: 17 February 2014
Olanzapine use in a manic patient during second and third trimester pregnancy
Choi L, Joo SH, Jeong JH
Neuropsychiatric Disease and Treatment 2014, 10:325-328
Published Date: 17 February 2014
Altered baseline brain activity in children with bipolar disorder during mania state: a resting-state study
Lu D, Jiao Q, Zhong Y, Gao W, Xiao Q, Liu X, Lin X, Cheng W, Luo L, Xu C, Lu G, Su L
Neuropsychiatric Disease and Treatment 2014, 10:317-323
Published Date: 17 February 2014
Risk factors associated with postpartum depression in the Saudi population
Alharbi AA, Abdulghani HM
Neuropsychiatric Disease and Treatment 2014, 10:311-316
Published Date: 17 February 2014
Frontotemporal lobar degeneration: current perspectives
Riedl L, Mackenzie IR, Förstl H, Kurz A, Diehl-Schmid J
Neuropsychiatric Disease and Treatment 2014, 10:297-310
Published Date: 13 February 2014
Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear
Masuda T, Inoue T, An Y, Takamura N, Nakagawa S, Kitaichi Y, Koyama T, Kusumi I
Neuropsychiatric Disease and Treatment 2014, 10:289-295
Published Date: 11 February 2014
Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation
Nakayama H, Umeda S, Nibuya M, Terao T, Nisijima K, Nomura S
Neuropsychiatric Disease and Treatment 2014, 10:283-287
Published Date: 11 February 2014
Screening for autism in preterm children with extremely low and very low birth weight
Dudova I, Kasparova M, Markova D, Zemankova J, Beranova S, Urbanek T, Hrdlicka M
Neuropsychiatric Disease and Treatment 2014, 10:277-282
Published Date: 11 February 2014
Tinnitus: clinical experience of the psychosomatic connection
Salviati M, Bersani FS, Terlizzi S, Melcore C, Panico R, Romano GF, Valeriani G, Macrì F, Altissimi G, Mazzei F, Testugini V, Latini L, Delle Chiaie R, Biondi M, Cianfrone G
Neuropsychiatric Disease and Treatment 2014, 10:267-275
Published Date: 10 February 2014
Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate- serotonin interaction
Strzelecki D, Szyburska J, Rabe-Jabłońska J
Neuropsychiatric Disease and Treatment 2014, 10:263-266
Published Date: 4 February 2014
Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?
Kume A
Neuropsychiatric Disease and Treatment 2014, 10:249-262
Published Date: 3 February 2014
Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder
Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J
Neuropsychiatric Disease and Treatment 2014, 10:243-248
Published Date: 3 February 2014
Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test
Ogrim G, Kropotov J, Brunner JF, Candrian G, Sandvik L, Hestad KA
Neuropsychiatric Disease and Treatment 2014, 10:231-242
Published Date: 3 February 2014
Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study
Zanotta D, Puricelli S, Bonoldi G
Neuropsychiatric Disease and Treatment 2014, 10:225-230
Published Date: 3 February 2014
Baseline characteristics of depressive disorders in Thai outpatients: findings from the Thai Study of Affective Disorders
Wongpakaran T, Wongpakaran N, Pinyopornpanish M, Srisutasanavong U, Lueboonthavatchai P, Nivataphand R, Apisiridej N, Petchsuwan D, Saisavoey N, Wannarit K, Ruktrakul R, Srichan T, Satthapisit S, Nakawiro D, Hiranyatheb T, Temboonkiat A, Tubtimtong N, Rakkhajeekul S, Wongtanoi B, Tanchakvaranont S, Bookkamana P
Neuropsychiatric Disease and Treatment 2014, 10:217-223
Published Date: 31 January 2014
A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
Wang G, McIntyre A, Earley WR, Raines SR, Eriksson H
Neuropsychiatric Disease and Treatment 2014, 10:201-216
Published Date: 30 January 2014
Predictors of repeated sick leave in the workplace because of mental disorders
Sado M, Shirahase J, Yoshimura K, Miura Y, Yamamoto K, Tabuchi H, Kato M, Mimura M
Neuropsychiatric Disease and Treatment 2014, 10:193-200
Published Date: 29 January 2014
Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia
Foster DJ, Choi DL, Conn PJ, Rook JM
Neuropsychiatric Disease and Treatment 2014, 10:183-191
Published Date: 28 January 2014
Design and validation of standardized clinical and functional remission criteria in schizophrenia
Mosolov SN, Potapov AV, Ushakov UV, Shafarenko AA, Kostyukova AB
Neuropsychiatric Disease and Treatment 2014, 10:167-181
Published Date: 28 January 2014
Building a new Rasch-based self-report inventory of depression
Balsamo M, Giampaglia G, Saggino A
Neuropsychiatric Disease and Treatment 2014, 10:153-165
Published Date: 28 January 2014
Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:147-151
Published Date: 24 January 2014
Pediatric neurofibromatosis 1 and parental stress: a multicenter study
Esposito M, Marotta R, Roccella M, Gallai B, Parisi L, Lavano SM, Carotenuto M
Neuropsychiatric Disease and Treatment 2014, 10:141-146
Published Date: 22 January 2014
Giant thrombosed intracavernous carotid artery aneurysm presenting as Tolosa–Hunt syndrome in a patient harboring a new pathogenic neurofibromatosis type 1 mutation: a case report and review of the literature
Conforti R, Cirillo M, Marrone V, Galasso R, Capaldo G, Giugliano T, Scuotto A, Piluso G, Melone MA
Neuropsychiatric Disease and Treatment 2014, 10:135-140
Published Date: 20 January 2014
Poor versus good sleepers in patients under treatment for sleep-related breathing disorders: better is not good enough
Veauthier C
Neuropsychiatric Disease and Treatment 2014, 10:131-133
Published Date: 17 January 2014
Mental health and burnout in primary and secondary school teachers in the remote mountain areas of Guangdong Province in the People's Republic of China
Zhang L, Zhao J, Xiao H, Zheng H, Xiao Y, Chen M, Chen D
Neuropsychiatric Disease and Treatment 2014, 10:123-130
Published Date: 17 January 2014
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review
Martin A, Abogunrin S, Kurth H, Dinet J
Neuropsychiatric Disease and Treatment 2014, 10:111-122
Published Date: 23 January 2014
Unmet needs in the management of schizophrenia
Torres-González F, Ibanez-Casas I, Saldivia S, Ballester D, Grandón P, Moreno-Küstner B, Xavier M, Gómez-Beneyto M
Neuropsychiatric Disease and Treatment 2014, 10:97-110
Published Date: 16 January 2014
Measuring quality of sleep and autonomic nervous function in healthy Japanese women
Sato M, Yasuhara Y, Tanioka T, Iwasa Y, Miyake M, Yasui T, Tomotake M, Kobayashi H, Locsin RC
Neuropsychiatric Disease and Treatment 2014, 10:89-96
Published Date: 17 January 2014
Balance deficits and ADHD symptoms in medication-naïve school-aged boys
Konicarova J, Bob P, Raboch J
Neuropsychiatric Disease and Treatment 2014, 10:85-88
Published Date: 15 January 2014
Incorporating and integrating cognitive event-related potentials in the management of psychiatric disorders
Bragazzi NL, Del Puente G
Neuropsychiatric Disease and Treatment 2014, 10:83-84
Published Date: 10 January 2014
Identifying the affected hemisphere with a multimodal approach in MRI-positive or negative, unilateral or bilateral temporal lobe epilepsy
Zhang J, Liu Q, Mei S, Zhang X, Liu W, Chen H, Xia H, Zhou Z, Wang X, Li Y
Neuropsychiatric Disease and Treatment 2014, 10:71-81
Published Date: 7 January 2014
Acute stimulation effect of the ventral capsule/ventral striatum in patients with refractory obsessive–compulsive disorder – a double-blinded trial
Tsai HC, Chang CH, Pan JI, Hsieh HJ, Tsai ST, Hung HY, Chen SY
Neuropsychiatric Disease and Treatment 2014, 10:63-69
Published Date: 6 January 2014
Relationship between alexithymia and coping strategies in patients with somatoform disorder
Tominaga T, Choi H, Nagoshi Y, Wada Y, Fukui K
Neuropsychiatric Disease and Treatment 2014, 10:55-62
Published Date: 27 December 2013
1H-Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder
BenAmor L
Neuropsychiatric Disease and Treatment 2014, 10:47-54
Published Date: 17 January 2014
Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease
Cui G, Yang X, Wang X, Zhang Z, Yue X, Shi H, Shen X
Neuropsychiatric Disease and Treatment 2014, 10:39-46
Published Date: 18 December 2013
Quality of life measurement and outcome in aphasia
Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A
Neuropsychiatric Disease and Treatment 2014, 10:27-37
Published Date: 17 December 2013
Total sleep deprivation decreases flow experience and mood status
Kaida K, Niki K
Neuropsychiatric Disease and Treatment 2014, 10:19-25
Published Date: 12 December 2013
Effects of maternal psychotropic drug dosage on birth outcomes
Michielsen LA, van der Heijden FMMA, Janssen PKC, Kuijpers HJH
Neuropsychiatric Disease and Treatment 2014, 10:13-18
Published Date: 10 December 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
Weisler RH, Adler LA, Kollins SH, Goodman DW, Hamdani M, Dirks B, Childress AC
Neuropsychiatric Disease and Treatment 2014, 10:1-12
Published Date: 9 December 2013